
Sign up to save your podcasts
Or


John Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
By The Lancet GroupJohn Beigel, an author, and Eddie Sullivan discuss a phase 1 study assessing the safety and tolerability of human antibodies manufactured in transchromosomic cows for treatment of MERS.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

7,625 Listeners

880 Listeners

140 Listeners

325 Listeners

497 Listeners

130 Listeners

3,369 Listeners

112,611 Listeners

56,603 Listeners

93 Listeners

368 Listeners

21 Listeners

0 Listeners

0 Listeners

2 Listeners

1 Listeners

0 Listeners

2 Listeners

0 Listeners

0 Listeners

0 Listeners

1 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

32 Listeners

83 Listeners

3 Listeners

0 Listeners

5 Listeners

0 Listeners

0 Listeners

0 Listeners